Leal T, et al. Identifying resistance to immune checkpoint inhibitors by screening for PD-L1 and MHC I expression on CTCS in pts with NSCLC. IASLC 2018; abstract P3.04-08.
Hyperbarezuurstoftherapie voor late toxiciteit na radiotherapie voor borstkanker
apr 2024 | Borstkanker, Radiotherapie